N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide
C25H24ClFN6O3S — CID 121427597
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide
N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide (PubChem CID 121427597) has the molecular formula C25H24ClFN6O3S and a molecular weight of 543.02 g/mol. Its IUPAC name is N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide.
Molecular Properties
| Compound Name | N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide |
|---|---|
| PubChem CID | 121427597 |
| Molecular Formula | C25H24ClFN6O3S |
| Molecular Weight | 543.02 g/mol |
| Exact Mass | 542.13 |
| IUPAC Name | N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-pyridinyl]-2-morpholin-4-ylethanesulfonamide |
| SMILES | O=S(=O)(CCN1CCOCC1)Nc1cncc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)c1 |
| InChI | InChI=1S/C25H24ClFN6O3S/c26-22-13-19(2-3-23(22)27)31-25-21-12-17(1-4-24(21)29-16-30-25)18-11-20(15-28-14-18)32-37(34,35)10-7-33-5-8-36-9-6-33/h1-4,11-16,32H,5-10H2,(H,29,30,31) |
| InChIKey | SZBBVQVIRGWQLM-UHFFFAOYSA-N |
| XLogP | 4.30 |
| TPSA | 109.34 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 543.02 |
| LogP ≤ 5 | 4.30 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121427597 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.